Aditxt Competitors

ADTX Stock

USD 0.60 0.02 3.23%

Aditxt Inc competes with VBI Vaccines, Denali Therapeutics, Vascular Biogenics, Dice Molecules, and DiaMedica Therapeutics; as well as few others. The company conducts business under Healthcare sector and is part of Biotechnology industry. Analyzing Aditxt competition allows you to expand the diversification possibilities of your existing portfolios and to get a better perspective on locking in new positions. Investors sometimes prefer comparable analysis of Aditxt to its intrinsic valuation because they are able to contrast its competitors on a relative basis.

You can use the Comparative Equity Analysis module to analyze the advantages of investing in your portfolio's related equities across multiple sectors and thematic ideas. Please use the input box below to enter symbols for particular investments you would like to analyze. With the equity comparison module, you can estimate the relative effect of Aditxt competition on your existing holdings. Check out Aditxt Correlation with its peers.

Return on Average Assets is likely to drop to -2.27 in 2023. Return on Average Equity is likely to drop to -4.72 in 2023. Aditxt Current Assets are fairly stable at the moment as compared to the past year. Aditxt reported Current Assets of 4.74 Million in 2022. Goodwill and Intangible Assets is likely to rise to about 146.4 K in 2023, whereas Total Assets are likely to drop slightly above 10.4 M in 2023.

Specify up to 10 symbols:

Sophisticated investors, who have witnessed many market ups and downs, frequently view the market will even out over time. This tendency of Aditxt's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy. Please use the tools below to analyze the current value of Aditxt in the context of predictive analytics.

Hype

Prediction

Low	Estimated	High
0.03	0.58	6.05

Details

Intrinsic

Valuation

Low	Real	High
0.07	1.45	6.92

Details

2 Analysts

Consensus

Low	Target	High
4.00	4.00	4.00

Details

Earnings

Estimates (2)

Low	Projected EPS	High
-2.89	-1.77	-0.64

Details

Please note, it is not enough to conduct a financial or market analysis of a single entity such as Aditxt. Your research has to be compared to or analyzed against Aditxt's peers to derive any actionable benefits. When done correctly, Aditxt's competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Aditxt Inc.

Aditxt Competition Correlation Matrix

Typically, diversification allows investors to combine positions across different asset classes to reduce overall portfolio risk. Correlation between Aditxt and its competitors represents the degree of relationship between the price movements of corresponding stocks. A correlation of about +1.0 implies that the price of Aditxt and its corresponding peer move in tandem. A correlation of -1.0 means that prices move in opposite directions. A correlation of close to zero suggests that the price movements of assets are uncorrelated; in other words, the historical price movement of Aditxt Inc does not affect the price movement of the other competitor.

Related Correlations

	VBIV	DNLI	VBLT	DICE	DMAC
VBIV		-0.45	-0.68	-0.54	-0.26	VBIV
DNLI	-0.45		0.76	0.57	0.73	DNLI
VBLT	-0.68	0.76		0.62	0.52	VBLT
DICE	-0.54	0.57	0.62		0.16	DICE
DMAC	-0.26	0.73	0.52	0.16		DMAC
	VBIV	DNLI	VBLT	DICE	DMAC

Click cells to compare fundamentals

Check Volatility

Backtest Portfolio

Risk-Adjusted Indicators

Nowadays, there is a big difference between Aditxt Stock performing well and Aditxt company doing well compared to the competition. There are way too many exceptions to the normal that investors can tell for sure what's good or bad unless they analyze Aditxt's multiple risk-adjusted performance indicators. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.

	Mean Deviation	Jensen Alpha	Sortino Ratio	Treynor Ratio	Semi Deviation	Information Ratio	Expected Shortfall	Potential Upside	Value At Risk	Maximum Drawdown
VBIV	6.45	(1.74)	0.00	(0.60)	0.00	(0.18)	0.00	12.30	(11.54)	59.79	VBI Vaccines Profile VBI Vaccines Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
DNLI	2.33	0.26	0.08	0.17	3.00	0.07	(2.42)	4.05	(5.11)	23.02	Denali Therapeutics Profile Denali Therapeutics Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
VBLT	4.22	0.49	0.08	0.56	3.73	0.09	(8.20)	11.76	(6.25)	23.81	Vascular Biogenics Profile Vascular Biogenics Dashboard Technical analysis Backtest News Timeline Fundamentals Trends
DICE	2.76	0.08	0.02	0.05	3.57	0.0222	(2.91)	6.80	(7.73)	15.55	Dice Molecules Profile Dice Molecules Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends
DMAC	3.91	0.70	0.19	(0.55)	3.56	0.13	(5.04)	6.64	(5.81)	33.89	DiaMedica Therapeutics Profile DiaMedica Therapeutics Dashboard Technical analysis Backtest News Timeline Analyst Consensus Fundamentals Trends

Cross Equities Net Income Analysis

Compare Aditxt Inc and related stocks such as VBI Vaccines, Denali Therapeutics, Vascular Biogenics, Dice Molecules Holdings, and DiaMedica Therapeutics Net Income Over Time

Select Fundamental

2010

2011

2012

2013

2014

2015

2016

2017

2018

2019

2020

2021

2022

2023

VBIV

(8.9 M)

(5.7 M)

(26.2 M)

(23.2 M)

(39 M)

(63.6 M)

(54.8 M)

(46.2 M)

(69.8 M)

(113.3 M)

(116.3 M)

DNLI

(16.8 M)

(86.7 M)

(88.2 M)

(36.2 M)

(197.6 M)

71.1 M

(290.6 M)

(326 M)

(334.6 M)

VBLT

(12.2 M)

(17.3 M)

(17.4 M)

(14.9 M)

(16 M)

(10.2 M)

(20.5 M)

(19.4 M)

(24.2 M)

(29.9 M)

(32.3 M)

(33.2 M)

DICE

(12.9 M)

(23.7 M)

(49 M)

(83.9 M)

(86.1 M)

DMAC

(2.2 M)

(4.3 M)

(5.7 M)

(10.6 M)

(12.3 M)

(13.6 M)

(13.7 M)

(14.8 M)

Aditxt Inc and related stocks such as VBI Vaccines, Denali Therapeutics, Vascular Biogenics, Dice Molecules Holdings, and DiaMedica Therapeutics Net Income description

Net income is one of the most important fundamental items in finance. It plays a large role in Aditxt Inc financial statement analysis. It represents the amount of money remaining after all of Aditxt Inc operating expenses, interest, taxes and preferred stock dividends have been deducted from a company total revenue. The portion of profit or loss for the period; net of income taxes; which is attributable to the parent after the deduction of Net Income to Non Controlling Interests from Consolidated Income; and before the deduction of Preferred Dividends.

Aditxt Competitive Analysis

The better you understand Aditxt competitors, the better chance you have of utilizing it as a position in your portfolios. From an individual investor's perspective, Aditxt's competitive analysis can cover a whole range of metrics. Some of these will be more critical depending on who you are as an investor and how you react to market volatility. However, if you are locking your investment sandscape to a long-term horizon, comparing the fundamental indicator across Aditxt's competition over several years is one of the best ways to analyze its investment potential.

Better Than Average

Worse Than Peers

View Performance Chart

	ADTX	VBIV	DNLI	VBLT	DICE	DMAC
	3.23 0.60 Aditxt	9.49 2.48 VBI	0.39 30.58 Denali	4.55 0.23 Vascular	4.95 32.41 Dice	8.15 2.92 DiaMedica
Market Volatility (90 Days Market Risk)	Dangerous	Relatively risky	Very steady	Out of control	Very steady	Risky
Market Performance (90 Days Performance)	Very Weak	Very Weak	OK	OK	Insignificant	OK
Odds of Financial Distress (Probability Of Bankruptcy)	Above Average	High	Very Low	Quite High	Close to Average	Below Average
Current Valuation (Equity Enterprise Value)	Under Valued	Under Valued	Under Valued	Over Valued	Under Valued	Under Valued
Buy or Sell Advice (Average Analysts Consensus)	Buy	Buy	Buy	Hold	Buy	Buy
Trade Advice (90 Days Macroaxis Advice)	Strong Sell	Cautious Hold	Strong Hold	Strong Hold	Strong Sell	Strong Sell
Number of Shares Shorted	185.3 K	563.96 K	8.63 M	812.53 K	8.01 M	83.56 K
Shares Owned by Insiders	0.96 %	0.52 %	14.59 %	12.87 %	3.32 %	27.98 %
Current Ratio	0.52 X	2.29 X	3.20 X	4.05 X	23.61 X	25.50 X
Net Asset	10.74 M	155.09 M	1.46 B	29.66 M	593.98 M	34.4 M
EBITDA	(24.28 M)	(81.82 M)	(330.36 M)	(31.16 M)	(83.01 M)	(13.98 M)
Operating Margin	(26.12) %	(59.27) %	(3.89) %	(49.93) %	N/A	N/A
Current Valuation	974.88 K	99.39 M	2.81 B	(17.68 M)	1.29 B	2.19 M
Cash Flow from Operations	(22.39 M)	(73.69 M)	(244.72 M)	(31.59 M)	(64.32 M)	(11.51 M)
Retained Earnings	(95.04 M)	(489.61 M)	(970.99 M)	(294.38 M)	(187.59 M)	(96.18 M)
Current Asset	N/A	7.89 M	281.74 M	38.59 M	N/A	5.24 M
Beta	1.56	1.83	1.33	0.68	N/A	1.74
Price to Book	0.52 X	1.56 X	4.75 X	0.35 X	5.91 X	1.08 X
Shares Outstanding	6.76 M	8.61 M	136.89 M	70.5 M	47.73 M	26.93 M
Total Debt	110.04 K	48.89 M	61.4 M	1.85 M	1.92 M	25 K
Return On Equity	(11.51) %	(1.37) %	(0.39) %	(0.88) %	(0.22) %	(0.46) %
Price to Earning	N/A	(3.79) X	60.91 X	(9.32) X	N/A	(3.52) X
Z Score	2.09	-5.54	39.97	-11.68	N/A	N/A
Shares Owned by Institutions	13.24 %	38.60 %	79.22 %	16.20 %	96.68 %	18.49 %
Return On Asset	(1.58) %	(0.33) %	(0.18) %	(0.44) %	(0.14) %	(0.28) %
Book Value Per Share	0.014 X	5.23 X	7.07 X	0.32 X	11.46 X	1.02 X
Cash and Equivalents	803.97 K	82.41 M	1.07 B	34.15 M	282.22 M	38.44 M
Current Liabilities	N/A	3.03 M	10.46 M	4.16 M	N/A	1.05 M
Price to Earnings To Growth	N/A	N/A	N/A	N/A	0.84 X	(0.07) X
Total Asset	10.74 M	155.09 M	1.46 B	29.66 M	593.98 M	34.4 M
Short Ratio	0.09 X	4.13 X	12.15 X	0.49 X	16.78 X	2.52 X
Target Price	4.0	4.0	58.64	5.0	61.3	7.5
Price to Sales	7.95 X	139.52 X	35.62 X	9.63 X	699.00 X	N/A
Market Capitalization	3.99 M	24.71 M	4.17 B	15.52 M	1.47 B	70.03 M
Cash per Share	0.71 X	0.32 X	8.66 X	0.49 X	7.39 X	1.45 X
Net Income	(27.65 M)	(113.3 M)	(325.99 M)	(32.3 M)	(83.89 M)	(13.68 M)
Earnings Per Share	(9.09) X	(13.39) X	(3.09) X	(0.33) X	(2.06) X	(0.55) X
Debt to Equity	3.21 %	0.32 %	0.07 %	0.05 %	0.05 %	N/A
Revenue	933.72 K	1.08 M	108.46 M	658 K	N/A	N/A
Working Capital	1.1 M	40.75 M	1.01 B	15.42 M	562.61 M	31.67 M
Gross Profit	166.94 K	(10.19 M)	(250.27 M)	554 K	(56.08 M)	N/A
Day Typical Price	0.61	2.58	30.55	0.22	31.86	2.87
Accumulation Distribution	4212.38	16423.58	26100.52	88277.83	13704.27	15255.1
Market Facilitation Index	0.0	0.0	0.0	N/A	0.0	0.0
Daily Balance Of Power	(0.50)	(0.76)	0.1412	0.5	0.8844	0.7333
Rate Of Daily Change	0.97	0.91	1.0	1.05	1.05	1.08
Day Median Price	0.61	2.63	30.54	0.22	31.59	2.85
Price Action Indicator	(0.02)	(0.28)	0.1	0.015	1.59	0.18
Coefficient Of Variation	(617.22)	(538.04)	1453.85	1192.35	5977.14	803.22
Mean Deviation	3.68	6.45	2.33	4.22	2.76	3.91
Jensen Alpha	(0.87)	(1.74)	0.257	0.4878	0.0831	0.6993
Total Risk Alpha	(0.70)	(1.52)	0.3237	0.644	0.1714	0.9331
Sortino Ratio	N/A	N/A	0.0762	0.0849	0.0226	0.1868
Downside Variance	N/A	N/A	10.57	33.75	13.23	16.99
Standard Deviation	5.32	9.82	3.31	5.64	3.71	6.02
Kurtosis	4.38	11.07	4.77	0.0841	0.8684	6.47
Potential Upside	7.02	12.3	4.05	11.76	6.8	6.64
Treynor Ratio	11.72	(0.60)	0.1662	0.563	0.0508	(0.55)
Maximum Drawdown	39.22	59.79	23.02	23.81	15.55	33.89
Variance	28.32	96.34	10.94	31.81	13.8	36.27
Market Risk Adjusted Performance	11.73	(0.59)	0.1762	0.573	0.0608	(0.54)
Risk Adjusted Performance	(0.14)	(0.17)	0.0718	0.0872	0.0232	0.1255
Skewness	(0.39)	(2.35)	0.762	0.7305	0.0229	2.05
Semi Deviation	N/A	N/A	3.0	3.73	3.57	3.56
Information Ratio	(0.16)	(0.18)	0.0749	0.0874	0.0222	0.1278
Value At Risk	(9.09)	(11.54)	(5.11)	(6.25)	(7.73)	(5.81)
Expected Short fall	N/A	N/A	(2.42)	(8.20)	(2.91)	(5.04)
Downside Deviation	N/A	N/A	3.25	5.81	3.64	4.12
Semi Variance	N/A	N/A	9.02	13.88	12.76	12.67

Aditxt Competition Performance Charts

Five steps to successful analysis of Aditxt Competition

Aditxt's competitive analysis is the process of researching and evaluating its competitive landscape. It provides an understanding of the strengths, weaknesses, opportunities, and threats (SWOT) faced by Aditxt Inc in relation to its competition. Aditxt's competition analysis typically involves several steps, including::

Identifying the key players in the market: This involves identifying the major competitors of Aditxt in the market, both direct and indirect, as well as new entrants and disruptive technologies.
Assessing the strengths and weaknesses of each competitor: This involves evaluating each competitor's strengths and weaknesses in areas such as product offerings, market share, brand recognition, financial performance, and distribution channels.
Understanding the competitive environment: This involves evaluating the regulatory environment, economic conditions, and other factors that may impact Aditxt's competitive landscape.
Identifying opportunities and threats: This involves using the information gathered during the analysis to identify opportunities and threats to Aditxt Inc, and developing a strategy to address them.
Evaluating the competitive landscape: This involves understanding the competitive dynamics of the market, such as pricing, marketing, and distribution strategies, as well as analyzing the competitive advantage of each competitor.

Competitive analysis is an essential tool for businesses to stay ahead of the competition and can be used to inform decision-making and strategy development. By understanding the competitive landscape and staying informed about the activities of competitors, a company can make more informed decisions and improve its overall performance.

Complement your Aditxt position

In addition to having Aditxt in your portfolios, you can quickly add positions using our predefined set of ideas and optimize them against your very unique investing style. A single investing idea is a collection of funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of investment themes. After you determine your investment opportunity, you can then find an optimal portfolio that will maximize potential returns on the chosen idea or minimize its exposure to market volatility.

Did You Try This Idea?

Run Investing Thematic Idea Now

Investing

Companies involved in money management and investment banking services. The Investing theme has 46 constituents at this time.

You can either use a buy-and-hold strategy to lock in the entire theme or actively trade it to take advantage of the short-term price volatility of individual constituents. Macroaxis can help you discover thousands of investment opportunities in different asset classes. In addition, you can partner with us for reliable portfolio optimization as you plan to utilize Investing Theme or any other thematic opportunities.

View All Next

Launch

Check out Aditxt Correlation with its peers. You can also try the CEO Directory module to screen CEOs from public companies around the world.

Complementary Tools for Aditxt Stock analysis

When running Aditxt's price analysis, check to measure Aditxt's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Aditxt is operating at the current time. Most of Aditxt's value examination focuses on studying past and present price action to predict the probability of Aditxt's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Aditxt's price. Additionally, you may evaluate how the addition of Aditxt to your portfolios can decrease your overall portfolio volatility.

	Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook.
	Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios
	Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account
	Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Insider Screener Find insiders across different sectors to evaluate their impact on performance
	Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets
	Share Portfolio Track or share privately all of your investments from the convenience of any device
	Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency
	Correlation Analysis Reduce portfolio risk simply by holding instruments which are not perfectly correlated
	CEO Directory Screen CEOs from public companies around the world

Is Aditxt's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Aditxt. If investors know Aditxt will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Aditxt listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(9.09)

Revenue Per Share

0.34

Quarterly Revenue Growth

0.039

Return On Assets

(1.58)

Return On Equity

(11.51)

The market value of Aditxt Inc is measured differently than its book value, which is the value of Aditxt that is recorded on the company's balance sheet. Investors also form their own opinion of Aditxt's value that differs from its market value or its book value, called intrinsic value, which is Aditxt's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Aditxt's market value can be influenced by many factors that don't directly affect Aditxt's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Aditxt's value and its price as these two are different measures arrived at by different means. Investors typically determine if Aditxt is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Aditxt's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2023 Macroaxis LLC

Working Capital	Tangible Assets Book Value per Share
Tangible Asset Value	Sales per Share
Return on Sales	Return on Invested Capital
Return on Average Equity	Return on Average Assets
Price to Sales Ratio	Price Sales Damodaran Method
Price to Earnings Ratio	Price Earnings Damodaran Method
Price to Book Value	Payout Ratio
Profit Margin	Market Capitalization
Invested Capital Average	Invested Capital
Gross Margin	Foreign Currency to USD Exchange Rate
Free Cash Flow per Share	Free Cash Flow
Enterprise Value over EBITDA	Enterprise Value over EBIT
Enterprise Value	Average Equity
Earnings per Basic Share USD	Earnings per Diluted Share
Earnings per Basic Share	Earnings before Tax
Earnings Before Interest Taxes and Depreciation Amortization USD	EBITDA Margin
Earnings Before Interest Taxes and Depreciation Amortization EBITDA	Dividends per Basic Common Share
Dividend Yield	Debt to Equity Ratio
Current Ratio	Book Value per Share
Asset Turnover	Average Assets
Total Assets Per Share	Net Assets Per Share
Cash Flow Per Share	Revenue Per Employee
Net Income Per Employee	Return on Investment
Operating Margin	Calculated Tax Rate
Receivables Turnover	Inventory Turnover
PPandE Turnover	Cash and Equivalents Turnover
Accounts Payable Turnover	Accrued Expenses Turnover
Interest Coverage	Long Term Debt to Equity
Quick Ratio	Net Current Assets as percentage of Total Assets
Revenue to Assets

Aditxt Competitors

Specify up to 10 symbols:

Aditxt Competition Correlation Matrix

Related Correlations

Risk-Adjusted Indicators

Cross Equities Net Income Analysis

Aditxt Inc and related stocks such as VBI Vaccines, Denali Therapeutics, Vascular Biogenics, Dice Molecules Holdings, and DiaMedica Therapeutics Net Income description

Aditxt Competitive Analysis

Aditxt Competition Performance Charts

Five steps to successful analysis of Aditxt Competition

Complement your Aditxt position

Did You Try This Idea?

Run Investing Thematic Idea Now

Investing

Complementary Tools for Aditxt Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY